ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $19,379,000 | +6.0% | 142,900 | 0.0% | 0.29% | +2.5% |
| Q4 2020 | $18,283,000 | +13.7% | 142,900 | 0.0% | 0.28% | -11.1% |
| Q3 2020 | $16,081,000 | +18.1% | 142,900 | 0.0% | 0.32% | +6.4% |
| Q2 2020 | $13,614,000 | +6.0% | 142,900 | 0.0% | 0.30% | -28.8% |
| Q1 2020 | $12,842,000 | +113.9% | 142,900 | +10.9% | 0.42% | +101.0% |
| Q1 2019 | $6,003,000 | +6.9% | 128,900 | 0.0% | 0.21% | -16.9% |
| Q4 2018 | $5,614,000 | -23.9% | 128,900 | 0.0% | 0.25% | -8.1% |
| Q3 2018 | $7,377,000 | -71.3% | 128,900 | -75.7% | 0.27% | -74.6% |
| Q2 2018 | $25,711,000 | +24.1% | 529,900 | 0.0% | 1.07% | +10.0% |
| Q1 2018 | $20,719,000 | -25.3% | 529,900 | -19.0% | 0.97% | -33.0% |
| Q4 2017 | $27,752,000 | +13.7% | 653,900 | 0.0% | 1.45% | +4.6% |
| Q3 2017 | $24,404,000 | +22.8% | 653,900 | 0.0% | 1.38% | +11.8% |
| Q2 2017 | $19,872,000 | +14.8% | 653,900 | 0.0% | 1.24% | +7.9% |
| Q1 2017 | $17,309,000 | +58.1% | 653,900 | +52.5% | 1.15% | +61.0% |
| Q4 2016 | $10,946,000 | -29.5% | 428,900 | 0.0% | 0.71% | -24.9% |
| Q3 2016 | $15,522,000 | +6.5% | 428,900 | 0.0% | 0.95% | +6.3% |
| Q2 2016 | $14,574,000 | +30.4% | 428,900 | +1.3% | 0.89% | +42.9% |
| Q1 2016 | $11,176,000 | +85.6% | 423,500 | +242.9% | 0.62% | +107.3% |
| Q4 2015 | $6,022,000 | +177.6% | 123,500 | +41.8% | 0.30% | +138.9% |
| Q3 2015 | $2,169,000 | -21.3% | 87,100 | 0.0% | 0.13% | -15.4% |
| Q2 2015 | $2,756,000 | -16.9% | 87,100 | 0.0% | 0.15% | -40.2% |
| Q1 2015 | $3,315,000 | +37.0% | 87,100 | +40.3% | 0.25% | -5.7% |
| Q4 2014 | $2,419,000 | +28.8% | 62,100 | 0.0% | 0.26% | +0.8% |
| Q3 2014 | $1,878,000 | -11.0% | 62,100 | 0.0% | 0.26% | -8.7% |
| Q2 2014 | $2,110,000 | – | 62,100 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
| Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
| Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
| QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
| Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
| WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
| EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
| Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |